Aim Immunotech Stock Fundamentals
| 0A4Y Stock | 0.23 0.01 4.55% |
AIM ImmunoTech fundamentals help investors to digest information that contributes to AIM ImmunoTech's financial success or failures. It also enables traders to predict the movement of AIM Stock. The fundamental analysis module provides a way to measure AIM ImmunoTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AIM ImmunoTech stock.
At this time, AIM ImmunoTech's Total Revenue is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 779.8 K in 2024, whereas Interest Income is likely to drop slightly above 422.2 K in 2024. AIM | Select Account or Indicator |
AIM ImmunoTech Company Shares Owned By Insiders Analysis
AIM ImmunoTech's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current AIM ImmunoTech Shares Owned By Insiders | 8.57 % |
Most of AIM ImmunoTech's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AIM ImmunoTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 8.57% of AIM ImmunoTech are shares owned by insiders. This is 20.57% lower than that of the Oil, Gas & Consumable Fuels sector and significantly higher than that of the Energy industry. The shares owned by insiders for all United Kingdom stocks is 15.06% higher than that of the company.
AIM ImmunoTech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AIM ImmunoTech's current stock value. Our valuation model uses many indicators to compare AIM ImmunoTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AIM ImmunoTech competition to find correlations between indicators driving AIM ImmunoTech's intrinsic value. More Info.AIM ImmunoTech is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AIM ImmunoTech's earnings, one of the primary drivers of an investment's value.AIM Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AIM ImmunoTech's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AIM ImmunoTech could also be used in its relative valuation, which is a method of valuing AIM ImmunoTech by comparing valuation metrics of similar companies.AIM ImmunoTech is currently under evaluation in shares owned by insiders category among its peers.
AIM Fundamentals
| Return On Equity | -1.55 | ||||
| Return On Asset | -0.8 | ||||
| Operating Margin | (73.88) % | ||||
| Current Valuation | 6.55 M | ||||
| Shares Owned By Insiders | 8.57 % | ||||
| Shares Owned By Institutions | 14.07 % | ||||
| Revenue | 201 K | ||||
| Gross Profit | (715 K) | ||||
| EBITDA | (31.36 M) | ||||
| Net Income | (19.45 M) | ||||
| Book Value Per Share | 0.19 X | ||||
| Earnings Per Share | (0.40) X | ||||
| Number Of Employees | 26 | ||||
| Beta | -0.36 | ||||
| Retained Earnings | (361.1 M) |
About AIM ImmunoTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AIM ImmunoTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AIM ImmunoTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AIM ImmunoTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 146.7 K | 191.8 K | |
| Cost Of Revenue | 725.4 K | 779.8 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.